Working... Menu

Protocol in Acute Myeloid Leukemia With FLT3-ITD

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01477606
Recruitment Status : Active, not recruiting
First Posted : November 22, 2011
Last Update Posted : May 17, 2019
Novartis Pharmaceuticals
Information provided by (Responsible Party):
Prof. Dr. Hartmut Doehner, University of Ulm